TENAX THERAPEUTICS, INC. (TENX)

Every figure this model derived for TENX, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2023-06-30
cash 118,000,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 121,663,000 AssetsCurrent 2026-06-30
current liabilities 8,073,000 LiabilitiesCurrent 2026-06-30
equity 113,590,000 StockholdersEquity 2026-06-30
interest expense 0 InterestExpenseDebt 2025-12-31
ocf -46,029,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 0 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 16,580,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up TENX on one particular measure came for.

RatioValue
current ratio15.07
current ratio reported15.07
dilution pct156.96
growth cv3.56

What to be careful about

What this model itself distrusts about TENX's figures. Written by the derivation as it ran, not added afterwards.